Background We aimed to describe pre-existing factors associated with severe disease,
primarily admission to critical care, and death secondary to SARS-CoV-2 infection in …

The COVID-19 pandemic has intensified the complications of plastic trash management and
disposal. The current situation of living in fear of transmission of the COVID-19 virus has …

Background Persistent respiratory symptoms after severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) in adults are frequent, and there can be long-term impairment …

Background Viral infections can cause significant morbidity in cystic fibrosis (CF). The
current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could …

There has been growing interest in telemedicine for cystic fibrosis over recent years based
largely on convenience for patients and/or increasing the frequency of surveillance and …

Background Acute respiratory distress syndrome (ARDS), a life-threatening condition
characterized by hypoxemia and poor lung compliance, is associated with high mortality …

Abstract Background Starting in November 2020, the US Food and Drug Administration
(FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the development of life-threatening COVID-19 are believed to disproportionately affect …

Background This international study aimed to characterise the impact of acute SARS-CoV-2
infection in people with cystic fibrosis and investigate factors associated with severe …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
people with cystic fibrosis (pwCF) can lead to severe outcomes. Methods In this …